|
TMED7-TICAM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.598300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.875640E-02 |
| Normal-vs-Stage2 |
6.919700E-02 |
| Normal-vs-Stage3 |
2.937700E-03 |
| Normal-vs-Stage4 |
1.037780E-02 |
| Stage1-vs-Stage2 |
9.387400E-01 |
| Stage1-vs-Stage3 |
3.055800E-01 |
| Stage1-vs-Stage4 |
3.542200E-01 |
| Stage2-vs-Stage3 |
5.439600E-01 |
| Stage2-vs-Stage4 |
5.433000E-01 |
| Stage3-vs-Stage4 |
8.742600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.765000E-03 |
| Normal-vs-AfricanAmerican |
7.139600E-02 |
| Normal-vs-Asian |
4.209200E-04 |
| Caucasian-vs-AfricanAmerican |
8.558200E-01 |
| Caucasian-vs-Asian |
1.111200E-01 |
| AfricanAmerican-vs-Asian |
5.589600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.176100E-03 |
| Normal-vs-Female |
1.255540E-02 |
| Male-vs-Female |
4.130600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.161200E-03 |
| Normal-vs-Age(41-60Yrs) |
7.155700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.154030E-01 |
| Normal-vs-Age(81-100Yrs) |
5.578200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.265200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.392400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.781600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.819000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.879800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.070600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.319600E-01 |
| Classical-VS-Follicular |
3.786800E-01 |
| Classical-VS-Other |
3.034000E-01 |
| Classical-VS-Normal |
7.519200E-03 |
| Tall-VS-Follicular |
3.936600E-01 |
| Tall-VS-Other |
4.820000E-01 |
| Tall-VS-Normal |
2.960300E-02 |
| Follicular-VS-Other |
2.977600E-01 |
| Follicular-VS-Normal |
1.685550E-01 |
| Other-VS-Normal |
3.175600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.534000E-02 |
| Normal-vs-N1 |
2.804300E-04 |
| N0-vs-N1 |
5.762300E-02 |
|
|
